European Vaccine Initiative (EVI)

Neglected Tropical Diseases (NTD), impact over 1 billion people worldwide.  Every year on 30th January the world commemorates #WorldNTDDay - a day to reflect on the progress we've made and renew our commitment to a future free from the burden of #NTDs. 🦠🦟 By fostering innovation, collaborations and awareness we can #BeatNTDs. Through European Vaccine Initiative (EVI) led projects, such as PREV_PKDL, we remain committed to providing innovative solutions through vaccines to fight against NTDs. 💉🙌🏾 Together, let’s ensure that no one is left behind in the fight against NTDs. Read more: https://lnkd.in/dfJW---D

📢 A new article arising from #Inno4Vac workshop on patient advocacy, ethics, and clinical trial design within Controlled Human Infection Models (CHIMs) has been just published! A Big Thank You to all participants and especially our invited external experts for their invaluable contributions! 🤝   The article affirms Inno4Vac’s commitment to #CHIM #research, fostering ethical, safe, and high-quality studies. Explore this thought-provoking report and join us in advancing CHIM research! ➡️ https://lnkd.in/d7x6Nvd3  --- 🤝 Danny Toomey, Paul Zimmer-Harwood, Meagan Deming, Simon Kolstoe, Joop van Gerven, Natalie Mazur, Oliver A. Cornely, Kristin G-I Mohn, Arno C. Andeweg, John Coia 🏢 European Vaccine Initiative (EVI)) Centre for Human Drug Research P95 University of Cologne Imperial College London IABS - International Alliance for Biological Standardization GSK Sanofi Sciensano UMC Utrecht German Center for Infection Research Leiden University Medical Center University of Oxford Paul-Ehrlich-Institut European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe products Regulatory Agency Stiftung Tierärztliche Hochschule Hannover University of Bergen (UiB) Viroclinics-DDL a Cerba Research Company European Medicines Agency, Agencia Española de Medicamentos y Productos Sanitarios, 1Day Sooner, University of Maryland School of Medicine, University of Portsmouth, Central Committee on Research Involving Human Subjects (CCMO), Syddansk Universitet - University of Southern Denmark --- #EUfunded #vaccine #bigdata #AI  #Innovation #RSV #Cdifficile #Influenza @Innovative Health Initiative (IHI) ---  This work has received support from the IMI2/EU/EFPIA Joint Undertaking Inno4Vac grant n° 

We’re thrilled to welcome Dr. Nicola Viebig back to European Vaccine Initiative (EVI) as our Director of Research! With 25+ years of experience in infectious diseases and extensive expertise managing international #vaccine development projects, Nicola brings exceptional #leadership to EVI. Previously EVI's Chief Scientific Officer, she most recently served as Director R&D Program Management at BioNTech SE. Her journey includes a PhD at Heidelberg University, postdoctoral work at the Institut Pasteur, and mentoring young researchers worldwide. We’re excited to have her back as we continue advancing vaccines for diseases of poverty and emerging infections. Welcome, Nicola! 🎉

🌟 Join our team! Exciting career opportunities at EVI 🌟 Looking to make an impact in global health? The European Vaccine Initiative (EVI) is hiring for two dynamic roles! 📌 Current Vacancies: 1. General Counsel 📍 Part-time or Full-time | Heidelberg, Germany, or Remote 2. Project Assistant with Event & HR Management Experience 📍 Part-time or Full-time | Heidelberg, Germany 💼 Why Join EVI? At EVI, we value diversity, dignity, and innovative thinking. Flexible working arrangements empower our team to excel while maintaining work-life balance. 📄 Learn more & Apply: Full job descriptions and application details here 👉https://lnkd.in/eZvwGY34 ⏳ Don’t miss this opportunity to make a difference in global health!

🦟 "The fight against malaria is one of the greatest challenges in the history of immunobiology". But a breakthrough is on the horizon. A new documentary follows a team of scientists from the University of Oxford who developed the R21/Matrix-M malaria vaccine - an innovation aiming for 75% effectiveness, a milestone previously unattained. The European Vaccine Initiative (EVI) is proud to have supported and contributed, alongside its partners, to the development of R21/Matrix-M over the years, advancing progress toward a new malaria vaccine. Let’s celebrate the progress and continue the fight for a malaria-free world! 🎯🌍 🎥 Watch now on ARTE: Malaria: Hoffnung in Sicht (in German and French) ➡https://lnkd.in/dg-ENmVh #MalariaFreeWorld #VaccinesWork #GlobalHealth #EndMalaria

During our fieldwork, we found that misconceptions about vaccines still persist. Some women feared harm to their unborn children, while others trusted traditional remedies over modern medicine.  Together, we can address fears and protect future generations. Read the final iteration of the personal account of our colleague Mandeep Kaur of the field work in Malawi.  "The Chronicles from Malawi"📝🌍 Episode 6 📔 Vaccines and advocacy: bridging the gap▶️ https://lnkd.in/eiATiMVq   #malawichronicles #GlobalHealth #PlacentalMalaria #Malaria #MaternalHealth 

🎯Now is the time to accelerate innovation, investment and collaboration to develop next-gen #malaria #vaccines. 🦟    At the The World Vaccine Congress 2024, an EVI-organised panel discussed lessons from licensed vaccines, strategies for second-generation development, and how novel technologies, like mRNA, and public-private partnerships can drive progress.  Key challenges such as affordability, regulatory alignment, and the need for validated immune correlates were also highlighted.    Thank you to our expert panellists Meta Roestenberg, Katie Ewer, Thierry Rolling, MD, MSc, Sumi Biswas and Irene Nailain Nkumama shedding light on these vital issues. 👏🏾 Learn more about the highlights of this lively discussion here ➡ https://lnkd.in/d4dkhvs7  #MalariaFreeWorld #VaccinesWork #GlobalHealth #EndMalaria 

It’s about relationships built on mutual respect. Engaging with communities is both rewarding and challenging. In rural Malawi, trust begins with local leaders. Their approval was vital for participant recruitment and understanding our study’s purpose. One unforgettable moment? Read the full account by our colleague Mandeep Kaur ⬇  "The Chronicles from Malawi"📝🌍 Episode 5 📔 Community engagement: building trust ▶️  https://lnkd.in/eiATiMVq  Don’t miss the final chronicle on 30 December 2024. #malawichronicles #PlacentalMalaria #Malaria #MaternalHealth #CommunityEngagement 

Malawi’s linguistic diversity brought richness—and challenges—to our fieldwork. While Chichewa is widely spoken, rural communities often use local dialects. This experience highlighted the beauty of language and the importance of cultural context in global health research. 🗣️💡 "The Chronicles from Malawi"📝🌍 Episode 4“… 📔 Lost in translation: bridging linguistic gaps in health terminology ➡ Stay tuned for the next chronicle on 26 December 2024. #malawichronicles #GlobalHealth #PlacentalMalaria #Malaria #MaternalHealth

Explore the European Vaccine Initiative (EVI)'s key highlights from the past year in our latest #newsletter! Read here ➡ https://lnkd.in/dGxzJzVh Want to stay updated on open calls, opportunities, and the latest developments? Subscribe to our newsletter today! ✍🏾https://lnkd.in/dMS-kU2H